BioMedica Diagnostics Inc. Company Profile

14:49 EDT 21st March 2018 | BioPortfolio

BioMedica Diagnostics Inc. is a Canadian Medical Devices Company with a dedicated focus on providing Affordable Medical Diagnostic Solutions.
The primary targets for our products are the emerging economies of the world, where the In Vitro Diagnostic (IVD) market continues to grow at an unprecedented annual rate of over 25%. In order to meet this growing business opportunity we have assembled a comprehensive package of appropriate equipment and reagent kits that combine all the desirable features demanded by this market


PO Box 1030
Nova Scotia
B0N 2T0


Phone: 1 (902) 798-5105
Fax: 1 (902) 798-1025

News Articles [435 Associated News Articles listed on BioPortfolio]

Oxford BioMedica set to earn $100 million in deal with Sanofi takeover target

UK gene cell therapy designer Oxford BioMedica’s shares jumped as much as 11.2% to 12.30 pence this…

Oxford BioMedica secures £3m grant from Innovate UK

Innovate UK has awarded Oxford BioMedica a £3m grant to support the UK's efforts to produce viral vectors and ensure adequate supply to meet future demand.

Oxford BioMedica a secures £3m grant from Innovate UK

Oxford BioMedica has been awarded a £3 million grant by the UK's innovation agency, Innovate UK, to support the UK's efforts to produce viral vectors and ensure adequate supply to meet future demand.

Oxford BioMedica, Bioverativ sign $100M deal to develop gene therapy material

Bioverativ awarded a $100 million contract to the UK's Oxford BioMedica to develop lentiviral vectors for use in Bioverativ's -More- 

Oxford BioMedica, Bioverativ to Develop Lentiviral Vectors for Hemophilia Gene Therapy

Oxford BioMedica said today it will partner with Bioverativ to develop and manufacture lentiviral vectors designed to treat hemophilia, through a collaboration that could generate up to $105 million-p...

Oxford Biomedica announces placing to inject £20.5m for expansion

Oxford Biomedica intends to raise approximately £20.5m by way of a conditional placing of ordinary shares to raise money for expansion of bioprocessing facilities, the company said on Friday. The p.....

Oxford BioMedica’s shares shares rise after unveiling US$100mln agreement with Bioverativ

Oxford BioMedica will receive a US$5mln payment upfront and will be eligible to receive various milestone payments potentially worth in excess of US$100mln

Oxford BioMedica wins second $100 million gene therapy contract

LONDON (Reuters) - Britain's Oxford BioMedica has won a second $100 million contract to supply gene therapy material, this time from Bioverativ, which agreed last month to be acquired by Sanofi for $1...

Drugs and Medications [20 Associated Drugs and Medications listed on BioPortfolio]

Oxygen [A.M. Home Diagnostics Inc. dba Healthline]


Cystografin dilute diatrizoate meglumine injection usp 18% [Bracco Diagnostics Inc.]

CYSTOGRAFIN DILUTE Diatrizoate Meglumine Injection USP 18%

Cystografin diatrizoate meglumine injection usp 30% [Bracco Diagnostics Inc.]

CYSTOGRAFIN Diatrizoate Meglumine Injection USP 30%

Multihance [Bracco Diagnostics Inc]

These highlights do not include all the information needed to use MultiHance safely and effectively. See full prescribing information for MultiHance. MultiHance (gadobenate dimeglumine) injection Init...

Reno-30 diatrizoate meglumine injection usp 30% [Bracco Diagnostics Inc.]

RENO-30 Diatrizoate Meglumine Injection USP 30%

PubMed Articles [280 Associated PubMed Articles listed on BioPortfolio]

Component resolved diagnostics for hymenoptera venom allergy.

Component-resolved diagnostics makes use of defined allergen molecules to analyse IgE-mediated sensitizations at a molecular level. Here, we review recent studies on the use of component-resolved diag...

Clinical Trials [185 Associated Clinical Trials listed on BioPortfolio]

Differential Diagnostics of Etiology of Acute Infections

Method for diagnostics of the origin of infections (bacterial vs viral) based on the identification of activation markers of blood neutrophils and monocytes will be developed.

Bedside vs. Standard Microbiological Blood Culture Diagnostics - BEMIDIA Study

With a completely bedside blood culture diagnostics system (BACTEC blood culture system in combination with the Accelerate ID/AST System) it is possible to optimize the initial antimicrobi...

MP Diagnostics HTLV Blot 2.4 Post-Market Clinical Study

The purpose of this study is to assess the performance of the HTLV Blot 2.4 from patients with the following conditions: infected with HTLV and neurological conditions with symptoms simila...

HIV Point-of-Care Test Evaluation in Infants

HIV Point-of-Care tests in Babies Study (BABY) - Operational evaluation of HIV Point-of-Care tests for very early infant HIV diagnostics in infants born to HIV infected mothers in Mbeya, T...

Evaluation of the Performance of Chembio Diagnostics Systems, Inc. DPP® HIV 1/2 Rapid Test

This study has been designed to evaluate the performance of the Chembio Diagnostics Systems, Inc. DPP® HIV 1/2 rapid test. The device is intended to qualitatively detect the presence of ...

Companies [920 Associated Companies listed on BioPortfolio]

BioMedica Diagnostics Inc.

BioMedica Diagnostics Inc. is a Canadian Medical Devices Company with a dedicated focus on providing Affordable Medical Diagnostic Solutions.The primary targets for our products are the emerging econo...

Acolyte Biomedica Ltd

Acolyte Biomedica Ltd provides rapid diagnostic systems for clinical microbiology. Acolyte's BacLite® platform allows microbial detection in hours instead of days, improving laboratory workflow, redu...


BIOMEDICA GRUPPE Is a privately owned group of Central European companies, founded in 1978, with head-quarters in Vienna (Austria). Starting as a single distributing company, only it grew to a group o...

Oxford BioMedica

Oxford BioMedica advanced gene therapy techniques.

Boston Biomedica Incorporated

Boston Biomedica, Inc. is an infectious diseases management company providing products and services for the detection and treatment of infectious diseases (ID) such as AIDS, Lyme Disease, and Viral He...

More Information about "BioMedica Diagnostics Inc." on BioPortfolio

We have published hundreds of BioMedica Diagnostics Inc. news stories on BioPortfolio along with dozens of BioMedica Diagnostics Inc. Clinical Trials and PubMed Articles about BioMedica Diagnostics Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of BioMedica Diagnostics Inc. Companies in our database. You can also find out about relevant BioMedica Diagnostics Inc. Drugs and Medications on this site too.

Quick Search


Corporate Database Quicklinks

Searches Linking to this Company Record